{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:38:27Z","timestamp":1761514707612,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011772","name":"Novartis Farmac\u00e9utica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s40618-020-01468-2","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T12:03:35Z","timestamp":1611230615000},"page":"1637-1648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The silent variants of pituitary tumors: demographic, radiological and molecular characteristics"],"prefix":"10.1007","volume":"44","author":[{"given":"M. E.","family":"Torregrosa-Quesada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Garc\u00eda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Barbie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Silva-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"issue":"5","key":"1468_CR1","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/EJE-15-0189","volume":"173","author":"TT Agustsson","year":"2015","unstructured":"Agustsson TT, Baldvinsdottir T, Jonasson JG et al (2015) The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol 173(5):655\u2013664. https:\/\/doi.org\/10.1530\/EJE-15-0189","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1468_CR2","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1210\/jc.2018-00688","volume":"104","author":"J Drummond","year":"2019","unstructured":"Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of silent pituitary adenomas. J Clin Endocrinol Metab 104(7):2473\u20132489. https:\/\/doi.org\/10.1210\/jc.2018-00688","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1468_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-14-0144","volume":"171","author":"A Tj\u00f6rnstrand","year":"2014","unstructured":"Tj\u00f6rnstrand A, Gunnarsson K, Evert M et al (2014) The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011. Eur J Endocrinol 171(4):519\u2013526. https:\/\/doi.org\/10.1530\/EJE-14-0144","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1468_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","volume":"117","author":"ED Aflorei","year":"2014","unstructured":"Aflorei ED, Korbonits M (2014) Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol 117(3):379\u2013394. https:\/\/doi.org\/10.1007\/s11060-013-1354-5","journal-title":"J Neurooncol"},{"issue":"3","key":"1468_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72(3):377\u2013382. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03667.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"1468_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF02914485","volume":"4","author":"G Kontogeorgos","year":"1993","unstructured":"Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW (1993) Null cell adenomas, oncocytomas, and gonadotroph adenomas of the human pituitary: an immunocytochemical and ultrastructural analysis of 300 cases. Endocr Pathol 4(1):20\u201327. https:\/\/doi.org\/10.1007\/BF02914485","journal-title":"Endocr Pathol"},{"issue":"3","key":"1468_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1227\/00006123-200009000-00039","volume":"47","author":"BW Scheithauer","year":"2000","unstructured":"Scheithauer BW, Jaap AJ, Horvath E et al (2000) Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 47(3):723\u2013730. https:\/\/doi.org\/10.1227\/00006123-200009000-00039","journal-title":"Neurosurgery"},{"issue":"4","key":"1468_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ijrobp.2014.07.013","volume":"90","author":"Z Xu","year":"2014","unstructured":"Xu Z, Ellis S, Lee CC et al (2014) Silent corticotroph adenomas after stereotactic radiosurgery: a case\u2013control study. Int J Radiat Oncol Biol Phys 90(4):903\u2013910. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1468_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/j.1365-2265.2009.03673.x","volume":"72","author":"HY Cho","year":"2010","unstructured":"Cho HY, Cho SW, Kim SW, Shin CS, Park KS, Kim SY (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf) 72(5):648\u2013653. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03673.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1468_CR10","first-page":"11","volume-title":"WHO classification of tumours of endocrine glands","author":"RY Osamura","year":"2017","unstructured":"Osamura RY, Lopes MBS, Grossman A, Kontogeorgos G (2017) WHO classification of tumours of the pituitary. In: Lloyd RV, Osamura RY, Kl\u00f6ppel RJ (eds) WHO classification of tumours of endocrine glands, 4th edn. Lyon, IARC, pp 11\u201363","edition":"4"},{"key":"1468_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198877","author":"A Garc\u00eda-Mart\u00ednez","year":"2018","unstructured":"Garc\u00eda-Mart\u00ednez A, Sottile J, Fajardo C et al (2018) Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours? PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0198877","journal-title":"PLoS ONE"},{"key":"1468_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180039","author":"L Sanchez-Tejada","year":"2017","unstructured":"Sanchez-Tejada L, Sanchez-Ortiga R, Lamas C et al (2017) Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0180039","journal-title":"PLoS ONE"},{"issue":"2","key":"1468_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12672-010-0014-x","volume":"1","author":"O Cooper","year":"2010","unstructured":"Cooper O, Ben-Shlomo A, Bonert V, Bannykh S, Mirocha J, Melmed S (2010) Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes. Horm Cancer 1(2):80\u201392. https:\/\/doi.org\/10.1007\/s12672-010-0014-x","journal-title":"Horm Cancer"},{"issue":"3","key":"1468_CR14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0002-9343(78)90236-X","volume":"64","author":"K Kovacs","year":"1978","unstructured":"Kovacs K, Horvath E, Bayley TA, Hassaram ST, Ezrin C (1978) Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med 64(3):492\u2013499. https:\/\/doi.org\/10.1016\/0002-9343(78)90236-X","journal-title":"Am J Med"},{"issue":"1","key":"1468_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-10-0076","volume":"163","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Jouanneau E et al (2010) Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing\u2019s disease. Eur J Endocrinol 163(1):35\u201343. https:\/\/doi.org\/10.1530\/EJE-10-0076","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1468_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1530\/EJE-07-0428","volume":"157","author":"T Tateno","year":"2007","unstructured":"Tateno T, Izumiyama H, Doi M et al (2007) Differential gene expression in ACTH-secreting and non-functioning pituitary tumors. Eur J Endocrinol 157(6):717\u2013724. https:\/\/doi.org\/10.1530\/EJE-07-0428","journal-title":"Eur J Endocrinol"},{"key":"1468_CR17","doi-asserted-by":"crossref","unstructured":"Tani Y, Sugiyama T, Izumiyama H, Yoshimoto T, Yamada S, Hirata Y (2011) Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors. Endocr J 58(4):297\u2013303. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21383526. Accessed 01 Feb 2018","DOI":"10.1507\/endocrj.K10E-389"},{"key":"1468_CR18","doi-asserted-by":"publisher","DOI":"10.3171\/2014.10.FOCUS14683","author":"J Seltzer","year":"2015","unstructured":"Seltzer J, Ashton CE, Scotton TC, Pangal D, Carmichael JD, Zada G (2015) Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature. Neurosurg Focus. https:\/\/doi.org\/10.3171\/2014.10.FOCUS14683","journal-title":"Neurosurg Focus"},{"issue":"3","key":"1468_CR19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1530\/EJE-19-0338","volume":"181","author":"A Garc\u00eda-Mart\u00ednez","year":"2019","unstructured":"Garc\u00eda-Mart\u00ednez A, Cano DA, Flores-Mart\u00ednez A et al (2019) Why don\u2019t corticotroph tumors always produce Cushing\u2019s disease? Eur J Endocrinol 181(3):351\u2013361. https:\/\/doi.org\/10.1530\/EJE-19-0338","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1468_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243. https:\/\/doi.org\/10.1007\/s12022-017-9498-z","journal-title":"Endocr Pathol"},{"issue":"9","key":"1468_CR21","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1210\/js.2019-00130","volume":"3","author":"BS Imber","year":"2019","unstructured":"Imber BS, Lin AL, Zhang Z et al (2019) Comparison of radiographic approaches to assess treatment response in pituitary adenomas: is RECIST or RANO good enough? J Endocr Soc 3(9):1693\u20131706. https:\/\/doi.org\/10.1210\/js.2019-00130","journal-title":"J Endocr Soc"},{"issue":"4","key":"1468_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space. Neurosurgery 33(4):610\u2013618. https:\/\/doi.org\/10.1097\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"issue":"1","key":"1468_CR23","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A et al (2018) European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1\u2013G24. https:\/\/doi.org\/10.1530\/EJE-17-0796","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1468_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","volume":"31","author":"O Mete","year":"2018","unstructured":"Mete O, Cintosun A, Pressman I, Asa SL (2018) Epidemiology and biomarker profile of pituitary adenohypophysical tumors. Mod Pathol 31(6):900\u2013909. https:\/\/doi.org\/10.1038\/s41379-018-0016-8","journal-title":"Mod Pathol"},{"issue":"4","key":"1468_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","volume":"26","author":"O Cooper","year":"2012","unstructured":"Cooper O, Melmed S (2012) Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab 26(4):447\u2013460. https:\/\/doi.org\/10.1016\/j.beem.2012.01.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1468_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF03401473","volume":"15","author":"G Kontogeorgos","year":"2016","unstructured":"Kontogeorgos G, Thodou E (2016) The gonadotroph origin of null cell adenomas. Hormones 15:243","journal-title":"Hormones"},{"issue":"4","key":"1468_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535. https:\/\/doi.org\/10.1007\/s00401-017-1769-8","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1468_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O et al (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26(4):349\u2013355. https:\/\/doi.org\/10.1007\/s12022-015-9398-z","journal-title":"Endocr Pathol"},{"issue":"2","key":"1468_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11102-017-0855-1","volume":"21","author":"E Manojlovic-Gacic","year":"2018","unstructured":"Manojlovic-Gacic E, Engstr\u00f6m BE, Casar-Borota O (2018) Histopathological classification of non-functioning pituitary neuroendocrine tumors. Pituitary 21(2):119\u2013129. https:\/\/doi.org\/10.1007\/s11102-017-0855-1","journal-title":"Pituitary"},{"issue":"12","key":"1468_CR30","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/cancers11121990","volume":"11","author":"ME Torregrosa-Quesada","year":"2019","unstructured":"Torregrosa-Quesada ME, Garc\u00eda-Mart\u00ednez A, Silva-Ortega S et al (2019) How valuable is the RT-qPCR of pituitary-specific transcription factors for identifying pituitary neuroendocrine tumor subtypes according to the new WHO 2017 criteria? Cancers (Basel) 11(12):1990. https:\/\/doi.org\/10.3390\/cancers11121990","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1468_CR31","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","volume":"26","author":"JA Balogun","year":"2015","unstructured":"Balogun JA, Monsalves E, Juraschka K et al (2015) Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol 26(1):63\u201370. https:\/\/doi.org\/10.1007\/s12022-014-9347-2","journal-title":"Endocr Pathol"},{"issue":"2","key":"1468_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1586\/17446651.2016.1153422","volume":"11","author":"SL Asa","year":"2016","unstructured":"Asa SL, Ezzat S (2016) Aggressive pituitary tumors or localized pituitary carcinomas: defining pituitary tumors. Expert Rev Endocrinol Metab 11(2):149\u2013162. https:\/\/doi.org\/10.1586\/17446651.2016.1153422","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1468_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020514","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa CC (2020) How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12020514","journal-title":"Cancers (Basel)"},{"key":"1468_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0838-2","author":"FF Casanueva","year":"2017","unstructured":"Casanueva FF, Barkan AL, Buchfelder M et al (2017) Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a pituitary Society Statement. Pituitary. https:\/\/doi.org\/10.1007\/s11102-017-0838-2","journal-title":"Pituitary"},{"issue":"8","key":"1468_CR35","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","volume":"154","author":"H Alahmadi","year":"2012","unstructured":"Alahmadi H, Lee D, Wilson JR et al (2012) Clinical features of silent corticotroph adenomas. Acta Neurochir (Wien) 154(8):1493\u20131498. https:\/\/doi.org\/10.1007\/s00701-012-1378-1","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"1468_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11102-014-0624-3","volume":"18","author":"O Cooper","year":"2015","unstructured":"Cooper O (2015) Silent corticotroph adenomas. Pituitary 18(2):225\u2013231. https:\/\/doi.org\/10.1007\/s11102-014-0624-3","journal-title":"Pituitary"},{"issue":"1","key":"1468_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11102-017-0844-4","volume":"21","author":"F Langlois","year":"2018","unstructured":"Langlois F, Lim DST, Yedinak CG et al (2018) Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review. Pituitary 21(1):32\u201340. https:\/\/doi.org\/10.1007\/s11102-017-0844-4","journal-title":"Pituitary"},{"issue":"3","key":"1468_CR38","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","volume":"61","author":"S Yamada","year":"2007","unstructured":"Yamada S, Ohyama K, Taguchi M et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580\u2013584","journal-title":"Neurosurgery"},{"issue":"3","key":"1468_CR39","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12020-017-1447-6","volume":"58","author":"F Langlois","year":"2017","unstructured":"Langlois F, Lim DST, Varlamov E et al (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience. Endocrine 58(3):528\u2013534. https:\/\/doi.org\/10.1007\/s12020-017-1447-6","journal-title":"Endocrine"},{"issue":"1","key":"1468_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1227\/01.neu.0000429858.96652.1e","volume":"73","author":"A Jahangiri","year":"2013","unstructured":"Jahangiri A, Wagner JR, Pekmezci M et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 73(1):8\u201317. https:\/\/doi.org\/10.1227\/01.neu.0000429858.96652.1e","journal-title":"Neurosurgery"},{"issue":"1","key":"1468_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11060-017-2520-y","volume":"135","author":"O Cohen-Inbar","year":"2017","unstructured":"Cohen-Inbar O, Xu Z, Lee CC et al (2017) Prognostic significance of corticotroph staining in radiosurgery for non-functioning pituitary adenomas: a multicenter study. J Neurooncol 135(1):67\u201374. https:\/\/doi.org\/10.1007\/s11060-017-2520-y","journal-title":"J Neurooncol"},{"issue":"2","key":"1468_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1227\/NEU.0b013e318257c1f0","volume":"71","author":"AG Ioachimescu","year":"2012","unstructured":"Ioachimescu AG, Eiland L, Chhabra VS et al (2012) Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. Neurosurgery 71(2):296\u2013303","journal-title":"Neurosurgery"},{"issue":"5\u20136","key":"1468_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ando.2013.09.003","volume":"74","author":"L Chinezu","year":"2013","unstructured":"Chinezu L, Jouanneau E, Vasiljevic A, Trouillas J, Raverot G (2013) Silent GH pituitary tumor: diagnostic and therapeutic challenges. Ann Endocrinol (Paris) 74(5\u20136):491\u2013495. https:\/\/doi.org\/10.1016\/j.ando.2013.09.003","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"1468_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-16-0738","volume":"176","author":"L Chinezu","year":"2017","unstructured":"Chinezu L, Vasiljevic A, Trouillas J, Lapoirie M, Jouanneau E, Raverot G (2017) Silent somatotroph tumour revisited from a study of 80 patients with and without acromegaly and a review of the literature. Eur J Endocrinol 176(2):195\u2013201. https:\/\/doi.org\/10.1530\/EJE-16-0738","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1468_CR45","first-page":"345","volume":"134","author":"K Kovacs","year":"1989","unstructured":"Kovacs K, Lloyd R, Horvath E et al (1989) Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134(2):345\u2013353","journal-title":"Am J Pathol"},{"issue":"8","key":"1468_CR46","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S0344-0338(11)81065-4","volume":"187","author":"J Trouillas","year":"1991","unstructured":"Trouillas J, Sassolas G, Loras B et al (1991) Somatotrpic adenomas without acromegaly. Pathol Res Pract 187(8):943\u2013949. https:\/\/doi.org\/10.1016\/S0344-0338(11)81065-4","journal-title":"Pathol Res Pract"},{"issue":"1","key":"1468_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1227\/00006123-199307000-00003","volume":"33","author":"S Yamada","year":"1993","unstructured":"Yamada S, Aiba T, Sano T et al (1993) Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 33(1):20\u201327. https:\/\/doi.org\/10.1227\/00006123-199307000-00003","journal-title":"Neurosurgery"},{"issue":"6","key":"1468_CR48","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2016-4061","volume":"102","author":"M Tampourlou","year":"2017","unstructured":"Tampourlou M, Ntali G, Ahmed S et al (2017) Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers. J Clin Endocrinol Metab 102(6):1889\u20131897. https:\/\/doi.org\/10.1210\/jc.2016-4061","journal-title":"J Clin Endocrinol Metab"},{"key":"1468_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203\u2013216","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1468_CR50","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.wneu.2014.03.031","volume":"82","author":"MA Kirkman","year":"2014","unstructured":"Kirkman MA, Jaunmuktane Z, Brandner S, Khan AA, Powell M, Baldeweg SE (2014) Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence. World Neurosurg 82(6):1224\u20131231. https:\/\/doi.org\/10.1016\/j.wneu.2014.03.031","journal-title":"World Neurosurg"},{"issue":"4","key":"1468_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12022-009-9094-y","volume":"20","author":"EL Wang","year":"2009","unstructured":"Wang EL, Qian ZR, Yamada S et al (2009) Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. Endocr Pathol 20(4):209\u2013220. https:\/\/doi.org\/10.1007\/s12022-009-9094-y","journal-title":"Endocr Pathol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01468-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T11:12:57Z","timestamp":1626433977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01468-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"type":"electronic","value":"1720-8386"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Samples were donated by patients to the Institutional BioBank for research purposes with the corresponding consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}